|
市場調査レポート
商品コード
1140682
バイオマテリアル創傷被覆材の世界市場-2022-2029Global Biomaterial Wound Dressing Market - 2022-2029 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
バイオマテリアル創傷被覆材の世界市場-2022-2029 |
出版日: 2022年10月20日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
|
創傷感染症の増加が予測期間中の市場成長を牽引
不衛生、糖尿病、肥満などによる創傷感染の発生率の増加が、創傷被覆材市場の成長に寄与しています。創傷被覆材は、感染部位に貼ることで創傷感染を軽減するために使用されます。感染症は不便で痛みを伴い、創傷治癒の失敗や遅延につながります。場合によっては、創傷感染が非常に深刻で、壊死性蜂巣炎や筋膜炎を引き起こしたり、局所の骨、腱、関節組織に広がったり、全身性疾患や脊椎などの遠隔部位への転移が起こったりします。
さらに、世界のバイオマテリアル創傷被覆材市場は、世界の手術件数の増加により、大きな成長を遂げています。さらに、形成外科手術の増加により、形成外科手術の創傷治癒に応用され、創傷被覆材市場を牽引しています。米国では、外科的および非外科的な美容整形手術が増加していることが大きいです。例えば、2021年には、米国で毒素やフィラーを含む550万以上の手術が行われ、49万1,000人が手術を行いました。
予測期間中、北米が支配的な地域です。
予測期間において、北米市場は世界のバイオマテリアル創傷被覆材市場で最大の市場シェアを占めています。北米市場の成長を補強する要因としては、褥瘡の発生率の増加や火傷の症例数の増加などが挙げられます。また、外科手術数の増加や大手企業の存在も、同市場の成長に寄与すると推定されます。
さらに、アジア太平洋地域は、アジア太平洋地域の経済圏全体における潰瘍の有病率、熱傷事例の増加、糖尿病の有病率の上昇と相まって高齢化が進んでおり、世界的に最も高いCAGRで成長すると予測されます。2020年には、中国の全人口の少なくとも17.8%に相当する2億5,500万人の高齢者が存在すると予想されています。年齢動態に伴い、アジア太平洋地域の人口における潰瘍の症例は増加すると予想され、創傷の可能性を高めると考えられています。
バイオマテリアル創傷被覆材市場は、少数の企業によって支配されています。市場成長の鍵を握る企業には、3M Company、ConvaTec Group PLC、DermaRite Industries LLC、B. Braun Melsungen AG、Hollister Incorporated、Integra LifeSciences Holdings Corporation、Johnson &Johnson、Medtronic PLCなどです。主要なプレーヤーは、製品の発売、買収、コラボレーションなどのいくつかの成長戦略を実行し、それが世界のバイオマテリアル創傷被覆材市場を後押しすると推定されます。2022年8月、The 3M Health Careの医療ソリューション事業は、特定の創傷ケア技術の提供を促進するためのアップグレードを発表しました。この新しいバイオマテリアル創傷ユニットは、3M VAC Ulta治療ユニットと名付けられ、顧客に対するコスト増なしで導入されました。軟部組織の開放創の患者さんに使用され、洗浄と肉芽組織の形成を促進するのに役立ちます。このキットは、創傷の即時浄化が必要な場合に、厚い組織や非生鮮組織を軟化、可溶化、破壊、除去するのに役立ちます。3M社は、幅広い創傷ケアソリューションを提供しています。3Mは、さまざまなドレッシングの適用を簡素化するために、新しいドレッシングキットを開発しました。2022年1月、コンバテックグループは、外科的創傷、慢性創傷、火傷におけるアンメットクリニカルニーズに対応する生物学的由来の革新的製品を開発するトライアッドライフサイエンス社を買収する正式契約を締結しました。この買収により、米国におけるConvatecのアドバンスト・ワウンド・ケアのポジションは強化され、アドバンスト・ワウンド・マネジメントと患者の転帰を向上させる革新的な技術プラットフォームが提供されることになります。
COVID-19の影響世界のバイオマテリアル創傷被覆材市場にネガティブな影響を与えます。
COVID-19のパンデミックの発生は、2020年のバイオマテリアル創傷被覆材市場の成長を狂わせると予想されます。事故や病院受診数の減少は、2020年のバイオマテリアル創傷被覆材市場の成長にネガティブな影響を与えている大きな要因です。しかし、COVID-19の汚染を避けるための厳格な戸締り条件や在宅勤務施設による交通事故の減少により、市場の悪影響が予想されます。
Biomaterial Wound Dressing Market is expected to grow at a CAGR of 10.8% during the forecasting period (2022-2029).
Biomaterial wound healing can be categorized in several ways, depending on its chemical nature, source, type of dressing, or application. Synthetic biomaterials consist of organic and inorganic polymers. In contrast, natural biomaterials include biological products derived from plant, fungal, animal, or bacterial sources that can, in turn, be divided into proteins, polysaccharides, or macromolecules combining proteins and polysaccharides. The rising incidence of chronic wounds such as ulcers is significantly creating the demand for wound dressing products, augmenting the market growth. The rising incidence of wound infection and an increasing number of surgeries also demand advanced and traditional wound care products.
Market Dynamics: Rising incidence of wound infection drives the market's growth during the forecast period.
The increasing incidence of wound infection due to poor hygiene, diabetes, obesity, and others contributes to the growth of the wound dressing market. The wound dressing is used to reduce the wound infection by placing it on the infection area. Infections are inconvenient and painful and lead to failure or delay in wound healing. In some cases, wound infection is very severe, causing necrotizing cellulitis or fasciitis; it spreads into the local bone, tendon, or joint tissues; systemic disease or metastatic spread to the spine or other distant sites.
Moreover, the global biomaterial wound dressing market is experiencing significant growth due to the increasing number of surgeries worldwide. Moreover, the increasing number of plastic surgeries is driving the wound dressing market due to its application for wound healing in plastic surgeries. The increasing number of surgical and nonsurgical cosmetic procedures in the United States is significant. For instance, in 2021, more than 5.5 million procedures involved toxins and fillers, and 491 thousand performed surgeries in the United States.
Market Segmentation: Hydrocolloid dressing segment accounted for the highest share in global biomaterial wound dressing market.
Hydrocolloid dressings are bandages made of gel-forming agents such as gelatin and pectin that form a moist environment with the body that promotes healing. The hydrocolloid dressings absorb fluid from the wound and are generally recommended for minor burns, leg ulcers, pressure sores, and traumatic injuries. Such dressings can be kept for several days, as it slowly aids the healing process and maintains the wound environment. Hydrocolloid dressings are available in the market in various shapes and sizes. The widely used hydrocolloid dressing brands available in the market include Duoderm GCF, Comfeel, Actiderm, and Hydrosol.
The biomaterial wound dressing market is classified into wounds, burns, ulcers, and others by the application. The wound segment held a significant share in the market growth. Wounds dominated the biomaterial wound dressing market in the forecast period. Surgical wound contributes majorly to segmental growth across the globe. A surgical wound is a cut that is generally made by using a scalpel during the surgical procedure. There are primarily two types of surgical wounds following surgery, including incisional wounds and excisional wounds. Incisional wounds are made by cutting through fat, skin, and muscle, enabling body parts to be removed or repaired. The biomaterial wound dressings play an important role in controlling any postoperative bleeding, offering protection to newly developed tissue, and easing pain.
Geographical Penetration: North America is the dominating region during the forecast period.
The North American market dominated the largest market share in the global biomaterial wound dressing market in the forecast period. Factors augmenting the North American market's growth include the increasing incidence of pressure ulcers and a rising number of burning injury cases. Further, the rising number of surgical procedures and the presence of major players are also estimated to contribute to the market's growth.
Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally due to the growing aging population coupled with the increasing prevalence of ulcers, increasing number of burn cases, and the rising prevalence of diabetes across the Asia Pacific economies. By 2020, there were 255 million elders, representing at least 17.8% of the entire Chinese population. With the age dynamics, ulcer cases among the population of Asia-Pacific are expected to grow, which is expected to increase the chances of wounds.
The biomaterial wound dressing market is dominated by a few companies. Some of the key players in the market's growth include 3M Company, ConvaTec Group PLC, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global biomaterial wound dressing market. In August 2022, The 3M Health Care's medical solutions business announced upgrades to advance the delivery of certain wound care technologies. This new biomaterial wound unit, named 3M VAC Ulta therapy unit, was introduced at no increased cost to the customer. It is used for patients with open soft tissue wounds to help cleanse and stimulate the formation of granulation tissue. This kit helps to soften, solubilize, disrupt, and remove thick and non-viable tissue when immediate wound cleansing is needed. 3M company offers a wide range of wound care solutions. 3M developed the new dressing kit to simplify various dressing applications. In January 2022, ConvaTec Group entered into a definitive agreement to acquire Triad Life Sciences Inc, which develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. This acquisition strengthens Convatec's Advanced Wound Care position in the United States and provides an innovative technology platform that enhances advanced wound management and patient outcomes.
COVID-19 Impact: Negative impact on the global biomaterial wound dressing market.
The outbreak of the COVID-19 pandemic is expected to derail the biomaterial wound dressing market's growth in 2020. The decline in accidents and the number of hospital visits is the major factor that has negatively impacted the biomaterial wound dressing market growth in 2020. However, the market is expected to have a negative impact due to the decrease in road accidents due to strict lockdown conditions and work-from-home facilities to avoid contamination of COVID-19.